

Incanthera PLC - Manchester-based oncology and dermatology treatments manufacturer - Sees its pretax loss widen in the year ended March 31 to GBP1.5 m...


(Alliance News) - Incanthera PLC and ImmuPharma PLC on Monday agreed a 12 month extension to their warrant instrument.


(Alliance News) - Incanthera PLC said on Wednesday that operating expenses were down as it remained focussed on developing its current lead pharmaceut...


(Alliance News) - Incanthera PLC on Friday reported a widened annual loss in a "very important year" for the company as it continued commercial discus...


EARNINGS UPDATES: Incanthera and Botswana Diamonds losses widen


IN BRIEF: Incanthera files for Sol skin cancer treatment trademark